Skip to main content
OpenTrials
Completed

NCT Number: NCT04089228

Kinesio Taping on Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

The aim of this research is to see the effects of kinesio taping after integrated neuromuscular inhibition technique on pain, disability, pain-pressure threshold and muscle length in patients with upper trapezius trigger points. There will be two groups experimental and control. One study group will receive kinesiotaping after integrated neuromuscular inhibition technique and the other group will only receive integrated neuromuscular inhibition technique.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Riphah International University

Islamabad, Federal, Pakistan, 44000, Pakistan

About this study

This study is Randomized controlled trail done at physiotherapy department of Railway General Hospital Rawalpindi. The sample size of 26 individuals calculated using open epi tool. Sampling technique applied was convenience sampling. Randomization in groups by sealed envelope method. The subjects were divided into two groups with 13 patients each. Both groups were treated with Integrated neuromuscular inhibition technique (Muscle energy Technique, sustain pressure, Strain counter-strain) while Kinesio tape was applied after INIT in only experimental group. Study duration was of 6 months. Individuals having age between 20-40 years, upper trapezius active or latent trigger points, limited side bending were included in this study. Tools used in the study were neck disability index (NDI), algometry, numeric pain rating scale (NPRS) and muscle length (side bending through inclinometer). Assessments were taken on 1st day pre and post intervention and on 4th day.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Upper Trapezius Active or latent trigger points
  • Limited range of motion (cervical Side Bending)

Exclusion criteria

  • Radiculopathies
  • Malignancy
  • Infection
  • Trauma

Treatment and study plan

Kinesiotaping

Other

Total of 4 sessions on upper trapezius trigger points on alternate days.

Integrated Neuromuscular Inhibition technique

Other

Sustain Pressure. Strain Counter-strain (for 90 sec) Passive Isometric Relaxation (PIR) (6-10 sec hold, 4 reps)

Primary outcomes

  1. Neck disability index

    Time frame: 4th Day

    Changes from the baseline, The NDI is a modification of the neck disability index and it was developed by Vernon and Mior. It was designed to measure the neck pain and disability over time. It consists of 10 items, five parts sections. At the end, score is calculated by dividing the obtained score by total 50 multiplied by 100.

  2. Pain-Pressure threshold (PPT)

    Time frame: 4th day

    Changes from the baseline, Pain-pressure threshold was measured with the help of an algometer.

  3. NPRS

    Time frame: 4th Day

    Changes from the baseline, Numeric Pain rating scale is a scale for pain intensity starting from 0-10. Where 0 indicates no pain and 10 indicate severe pain.

Secondary outcomes

  1. Muscle length measure

    Time frame: 4th Day

    Changes from the baseline, Muscle length of upper trapezius was measured with the help of Inclinometer

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Kinesio Taping on Upper Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 13, 2019
Registry last updated
Sep 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.